USD 66.97 billion
Global Biomarkers Market Size, Share, Growth Analysis, By Type(Safety, Efficacy), By Application(Diagnostics, Drug discovery & development), By Disease(Cancer, Cardiovascular Diseases) - Industry Forecast 2024-2031
Report ID:
SQMIG35A2509 |
Region:
Global |
Published Date: April, 2024
Pages:
219
|
Tables:
92 |
Figures:
76
Global Biomarkers Market Insights
Global Biomarkers Market size was valued at around USD 66.97 billion in 2022 and is expected to rise from USD 75.88 billion in 2023 to reach a value of USD 206.04 Billion by 2031, at a CAGR of 13.3% over the forecast period (2024–2031).
Growth in the company is anticipated to be driven by factors including the growing importance of companion diagnostics, an increase in cancer prevalence, rising funding in biomarker research, and important discoveries as a result of ongoing research. For instance, in October 2022, researchers from Boston University obtained funding from the National Institutes of Health totaling USD 4.6 million to develop novel lung cancer biomarkers. A further aspect influencing market growth is technological progress in the creation of biomarker-based diagnostics.
The discovery of potent medicines for the management of numerous illnesses, including cancer, cardiovascular, immunological, and neurological diseases, is made possible through research. Additionally, it aids in comprehending the methods for early detection and prevention of a specific disease. The amount of public and private investment in the sector has grown, it has been noted. For instance, Quanterix Corp. declared in March 2022 that the Alzheimer's Drug Discovery Foundation has granted financing to hasten the development of a diagnostic plasma test for Alzheimer's disease. Clinical application of plasma-based biomarkers for Alzheimer's disease diagnosis is imminent.
The role of biomarkers in the diagnosis of infectious diseases is anticipated to witness significant growth in the coming years. As an illustration, according to Frontiers in Microbiology in 2021, possible MicroRNA-based biomarkers have been found for the identification of illnesses such as rhinoviruses, influenza infections, tuberculosis, HIV, malaria, Ebola, and Hendra virus. These miRNA-based indicators are meant to aid in the early identification of infectious illnesses. Additionally, biomarkers are used in the management of neurological diseases to quantify molecules and monitor the condition of the brain. Due to recent advancements in biomarkers, such as biomarker signatures, the treatment of neurological illnesses is becoming increasingly effective.
Recent developments in the biomarkers market allow safe testing, more quickly manufacturing of drugs, and quicker diagnosis. For instance, Altoida collaborated with the Digital Medicines Society (DiMe) in March 2022 to improve its platform for next-generation precision neuro-biomarkers. Leading players are also concentrating on providing programmes that might boost the marketing of biomarker-based goods. For instance, Amgen, Inc. launched the Biomarker Assist programme in April 2021 to provide financial assistance to metastatic NSCLC patients so they may receive biomarker testing. Biomarker Assist is made up of the NGS Affordability Programmes and the KRAS Single Gene Test (SGT).
US Biomarkers Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Safety
Fastest Growth
Efficacy
Growth Rate
13.3% CAGR
Global Biomarkers Market ($ Bn)
Country Share for North America Region (%)
Global Biomarkers Market By Type ($ Bn)
Global Biomarkers Market By Type (%)
To get more reports on the above market click here to Buy The Report
Global Biomarkers Market Segmental Analysis
The global biomarkers market is segmented based on type, application, disease, and region. In terms of type, the market is classified into safety, efficacy, and validation. With respect to application, the market is categorized into diagnostics, drug discovery & development, personalized medicine, and others. In terms of disease, the market is segmented into cancer, cardiovascular diseases, neurological diseases, and immunological diseases. Regionwise, the global biomarkers market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Biomarkers Market Analysis by Type
The safety category had the biggest market share and was responsible for more than 37.80% of total revenue. The segment is expected to expand at a notable rate during the forecast period.. The expansion of the segment is predicted to be fueled by an increase in the usage of safety biomarkers in medication research and development. Additionally, it is anticipated that a growing portion of the population will be at a high risk of contracting diseases like kidney disorders, cancer, and cardiovascular conditions.
Additionally, factors contributing to segment growth include rising public awareness of the importance of regular health screenings and a decline in drug attrition rate, which is associated with biomarker-based therapies. Over the anticipated period, effective biomarkers are expected to grow at a profitable rate. Effectiveness biomarkers aid in predicting a patient's reaction to a given medication. Numerous results on efficacy biomarkers have been reported despite research challenges. One such biomarker is ATPase-copper Transporting Polypeptide (ATP7B), which is used to identify ovarian cancer.
Biomarkers Market Analysis by Application
The market was led by the drug discovery and development industry in 2022, with a revenue share of over 32.85%. It is estimated to increase at a notable CAGR during the forecast period. This segment has grown as a result of significant R&D efforts by leading companies, growing usage of biomarkers in medication research, and ongoing strategic alliances in biomarkers discovery. For instance, InterVenn Biosciences collaborated with the Foundation for the National Institutes of Health's Biomarker Consortium and the Worldwide Innovative Network (WIN) Consortium in June 2022.
The category is likely to expand due to the rising use of personalized medicine for chronic diseases, high pharmacogenomics penetration, and rising awareness of personalized medicine among healthcare professionals. Additionally, segment expansion is aided by the strategic initiatives taken by top participants. For instance, in March 2021, Oxford BioDynamics and Agilent Technologies, Inc. inked a reseller and supply agreement for the array kit EpiSwitch Explorer, which may be used for biomarker identification and is a crucial part of the personalized medicine market.
Global Biomarkers Market By Type, 2023 (%)
To get detailed analysis on other segments, Request For Free Sample Report
Global Biomarkers Market Regional Insights
North America dominated the global biomarkers business in 2022 with a revenue share of more than 44.00% due to the high illness burden, increased consumer awareness of biomarkers, encouraging government initiatives, technical breakthroughs, and improvements in healthcare infrastructure. The presence of important enterprises in this area and the numerous organic and inorganic developments they have undertaken are crucial factors projected to fuel the region's growth. For instance, Akoya Biosciences, Inc. announced in November 2022 the availability of PhenoCode signature panels for high-throughput spatial biomarker discovery.
Asia Pacific, on the other hand, is anticipated to grow at the fastest rate throughout that time. A surge in funding for biomarker development, a high cancer prevalence, rising research activities, and reasonably priced clinical trials in developing nations are factors that are projected to boost regional expansion. Additionally, it is anticipated that an increase in funding for biotech and pharmaceutical companies, an increase in the number of CROs, and a broadening of the use of biomarkers will support regional market expansion during the anticipated time frame.
Global Biomarkers Market By Region, 2024-2031
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Global Biomarkers Market Dynamics
Biomarkers Market Drivers
Growing Demand for Personalized Medicine
- The demand for personalized medicine is increasing, as it allows for more targeted and effective treatments for individual patients. Biomarkers play a critical role in personalized medicine, as they can be used to identify patient-specific molecular signatures that can guide treatment decisions.
Biomarkers Market Restraints
Lack of Standardization
- There is a lack of standardization in the biomarker discovery and development process, which can lead to variability in the quality and reliability of biomarker tests. This can hinder the adoption of biomarkers in clinical practice, and can also lead to regulatory challenges.
Request Free Customization of this report to help us to meet your business objectives.
Global Biomarkers Market Competitive Landscape
To enhance their market share, major firms are implementing tactics including new product development, merger & acquisition, and collaboration. A number of market participants, including Abbott and F. Hoffmann-La Roche Ltd., are actively working on developing new biomarker solutions. To increase access to individualized oncology biomarker testing, Thermo Fisher Scientific, Inc. introduced CE-IVD (IVDD) NGS test and analysis software in August 2022.
Biomarkers Market Top Player’s Company Profiles
- QIAGEN N.V.
- Bio-Rad Laboratories, Inc.
- Merck & Co., Inc.
- PerkinElmer, Inc.
- Illumina, Inc.
- BD (Becton, Dickinson and Company)
- Myriad Genetics, Inc.
- Siemens Healthineers AG
- Danaher Corporation
- Biomerieux SA
- Waters Corporation
- Abbott Laboratories
- Sysmex Corporation
- Bio-Techne Corporation
- Charles River Laboratories International, Inc.
- Eurofins Scientific SE
- Pacific Biomarkers, Inc.
Biomarkers Market Recent Developments
- In April 2024, Nucleai, a pioneer in spatial AI biomarkers raised $14M in funding led by M Ventures, the corporate venture arm of Merck KGaA.
- In April 2024, Takara Bio USA, Inc., a wholly owned subsidiary of Japan headquartered Takara Bio Inc., announced the launch of the Shasta Single-Cell System, an automated, high-throughput next-generation sequencing (NGS) solution with well-validated chemistries and intuitive bioinformatics tools that enables novel biomarker discovery for oncology research.
- In April 2024, Cizzle Biotechnology Holdings plc, the UK based diagnostics developer, announced that it has signed a non-binding MoU for a strategic and exclusive licensing agreement to develop and offer its proprietary test for the CIZ1B biomarker which is highly associated with early-stage lung cancer, throughout the USA and Canada.
Global Biomarkers Key Market Trends
- Increasing Use of Companion Diagnostics: Companion diagnostics are tests that are designed to identify biomarkers that indicate whether a patient is likely to benefit from a particular therapy or not. These tests are becoming increasingly important in drug development and personalized medicine. As a result, the market for companion diagnostics is growing rapidly, with many pharmaceutical companies partnering with diagnostic companies to develop and commercialize these tests.
- Growing Interest in Liquid Biopsy: Liquid biopsy is a non-invasive diagnostic technique that involves the analysis of biomarkers in a patient's blood or other bodily fluids. This technique is gaining increasing interest in the biomarkers market, as it allows for earlier detection of cancer and other diseases, and can also be used to monitor treatment response. Several companies are now developing liquid biopsy tests, and the market is expected to grow rapidly in the coming years.
- Increasing Use of Biomarkers in Drug Development: Biomarkers are playing an increasingly important role in drug development, as they can be used to identify drug targets, predict drug efficacy and toxicity, and monitor treatment response. Pharmaceutical companies are now using biomarkers to guide their drug development programs, which is helping to accelerate the development of new therapies.
- Rising Demand for Personalized Medicine: Personalized medicine involves the use of biomarkers to identify patient-specific molecular signatures that can guide treatment decisions. The demand for personalized medicine is increasing, as it allows for more targeted and effective treatments for individual patients. Biomarkers are playing a critical role in personalized medicine, and the market for biomarker-based tests and treatments is expected to grow rapidly in the coming years.
Global Biomarkers Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyzes the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to our global biomarkers market analysis, we found that the growing importance of companion diagnostics, an increase in cancer prevalence, rising funding in biomarker research, and important discoveries as a result of ongoing research are the key factors augmenting the growth of this market. For instance, in October 2022, researchers from Boston University obtained funding from the National Institutes of Health totaling USD 4.6 million to develop novel lung cancer biomarkers. A further aspect influencing market growth is technological progress in the creation of biomarker-based diagnostics.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 66.97 billion |
| Market size value in 2031 | USD 206.04 Billion |
| Growth Rate | 13.3% |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Global Biomarkers Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Global Biomarkers Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Global Biomarkers Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Biomarkers Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Biomarkers Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global Biomarkers Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Global Biomarkers Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
